• Facebook
  • X
Phone: (843) 449-1010 | 823 82nd Parkway, Suite B, Myrtle Beach, SC 29572
Carolina Urologic Research Center - Myrtle Beach, SC
  • Home
  • About Us
  • Staff
    • Clinical Investigators
    • Clinical Staff
    • Associated Providers
  • Current Trials
    • Bladder Cancer
    • Prostate Cancer
    • Other
    • Patient Trials Form
  • Patient Info
    • Patient Info
    • Helpful Links
    • Q&A About Clinical Trials
  • Testimonials
  • In The News
    • In The News
  • Contact
  • Search
  • Menu Menu
Blog - Latest News
You are here: Home1 / Dr. Shore Conducts the Poster Presentation at the SUO 2015 Conference in Washington, DC “Significant Reduction in Therapeutic Burden from Use of CCP Test in Treatment Decisions among Newly Diagnosed Prostate Cancer Patients in a Large Prospective Registry” Please join us Wednesday, 12/2 • 4:30pm2 / 12.1-Prolaris

12.1-Prolaris

December 1, 2015/by CURC

Share this entry
  • Share on Facebook
  • Share on X
  • Share on X
  • Share on WhatsApp
  • Share on Pinterest
  • Share on LinkedIn
  • Share on Tumblr
  • Share on Vk
  • Share on Reddit
  • Share by Mail
/wp-content/uploads/logo-1.png 0 0 CURC /wp-content/uploads/logo-1.png CURC2015-12-01 09:08:342015-12-01 09:08:3412.1-Prolaris

Current Happenings

  • Development of TAR-200: A novel targeted releasing system designed to provide sustained delivery of gemcitabine for patients with bladder cancer
  • Pfizer’s Sasanlimab in Combination with BCG Improves Event-Free Survival in Patients with BCG-Naïve, High-Risk Non-Muscle Invasive Bladder Cancer
  • Implementation of Universal Germline Genetic Testing Into Standard of Care for Patients With Prostate Cancer: The Time Is Now
  • In the Era of Treatment Intensification for Prostate Cancer, Why Are Some Living in the Past?
  • Editorial Comment: Integrating Broad Panel Somatic and Germline Testing in Prostate Cancer Care
  • Evaluating the Importance of Practice-level Factors on Adherence to Prostate Cancer Treatment Guidelines in Urology
  • Testosterone recovery post discontinuation of androgen deprivation for the treatment of advanced prostate cancer
  • The landscape of androgen deprivation therapies for the treatment of advanced prostate cancer

Archives

Contact

Carolina Urologic Research Center
823 82nd Parkway, Suite B
Myrtle Beach, SC 29572

Phone: (843) 839-1679
Fax: (843) 286-0119

Email:
info@curcmb.com

Directions

Recent Happenings

  • Development of TAR-200: A novel targeted releasing system designed to provide sustained delivery of gemcitabine for patients with bladder cancer
  • Pfizer’s Sasanlimab in Combination with BCG Improves Event-Free Survival in Patients with BCG-Naïve, High-Risk Non-Muscle Invasive Bladder Cancer
  • Implementation of Universal Germline Genetic Testing Into Standard of Care for Patients With Prostate Cancer: The Time Is Now
  • In the Era of Treatment Intensification for Prostate Cancer, Why Are Some Living in the Past?

Our Affiliates

©2025 Carolina Urologic Research Center, LLC | All Rights Reserved | Site Design by Studio303, Inc.
  • Facebook
  • X
Scroll to top